Clari Vest Asset Management LLC Esperion Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$31.18 - $52.71 $2.04 Million - $3.44 Million	-65,304 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$30.04 - $51.31 $71,555 - $122,220	2,382 Added 3.79%	65,304 $3.35 Million
Q1 2020 May 04, 2020	SELL	$27.44 - $73.84 $90,908 - $244,631	-3,313 Reduced 5.0%	62,922 $1.98 Million
Q4 2019 Feb 12, 2020	SELL	$35.4 - $59.82 $769,666 - $1.3 Million	-21,742 Reduced 24.71%	66,235 $3.95 Million
Q3 2019 Nov 12, 2019	SELL	$34.47 - $47.53 $34,470 - $47,530	-1,000 Reduced 1.12%	87,977 $3.23 Million
Q2 2019 Aug 16, 2019	BUY	$40.1 - $52.33 $3.57 Million - $4.66 Million	88,977 New	88,977 $4.14 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.